The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Market Cap	9.28B
Revenue (ttm)	11.80B
Net Income (ttm)	632.83M
Shares Out	31.24M
EPS (ttm)	20.25
PE Ratio	14.66
Forward PE	12.85
Dividend	6.30 (2.13%)
Ex-Dividend Date	Oct 27, 2025

Volume	77,090
Average Volume	45,152
Open	n/a
Previous Close	295.80
Day's Range	273.80 - 302.70
52-Week Range	267.00 - 334.80
Beta	0.17
RSI	33.55
Earnings Date	Sep 30, 2025

About DSE:IBNSINA

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 4,200
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In 2024, DSE:IBNSINA's revenue was 11.37 billion, an increase of 24.61% compared to the previous year's 9.13 billion. Earnings were 670.52 million, an increase of 10.75%.